EPO, erythropoietin, 2056

N. diseases: 646; N. variants: 11
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0271979
Disease: Thalassemia Intermedia
Thalassemia Intermedia
0.330 Biomarker disease BEFREE We generated a murine model of thalassemia intermedia specifically lacking BM <i>Tfr2</i>: because their erythroid cells are more susceptible to EPO stimulation, mice show improved erythropoiesis and red blood cell morphology as well as partial correction of anemia and iron overload. 30209118 2018
CUI: C0271979
Disease: Thalassemia Intermedia
Thalassemia Intermedia
0.330 AlteredExpression disease BEFREE We assessed the degree of iron overload in thalassemia intermedia and major patients by measuring hepatic iron concentration in liver biopsy samples and serum ferritin, estimated erythropoietic drive by assaying soluble transferrin receptor and serum erythropoietin levels and correlated these with urinary hepcidin measurements. 17488680 2007
CUI: C0271979
Disease: Thalassemia Intermedia
Thalassemia Intermedia
0.330 Therapeutic disease CTD_human Fetal haemoglobin augmentation in E/beta(0) thalassaemia: clinical and haematological outcome. 16225658 2005
CUI: C0271979
Disease: Thalassemia Intermedia
Thalassemia Intermedia
0.330 Biomarker disease BEFREE Serum erythropoietin and circulating transferrin receptor in thalassemia intermedia patients with heterogeneous genotypes. 8952151 1997